These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
243 related items for PubMed ID: 22659097
1. Glucocorticoid-resistant asthma and novel anti-inflammatory drugs. Keenan CR, Salem S, Fietz ER, Gualano RC, Stewart AG. Drug Discov Today; 2012 Sep; 17(17-18):1031-8. PubMed ID: 22659097 [Abstract] [Full Text] [Related]
2. Pharmacological strategies for improving the efficacy and therapeutic ratio of glucocorticoids in inflammatory lung diseases. Newton R, Leigh R, Giembycz MA. Pharmacol Ther; 2010 Feb; 125(2):286-327. PubMed ID: 19932713 [Abstract] [Full Text] [Related]
3. Resistance to glucocorticoids: another piece of the jigsaw. Ramos-Barbón D. Arch Bronconeumol; 2011 Mar; 47(3):113-4. PubMed ID: 21396762 [No Abstract] [Full Text] [Related]
4. Glucocorticoids: mechanisms of action and anti-inflammatory potential in asthma. van der Velden VH. Mediators Inflamm; 1998 Mar; 7(4):229-37. PubMed ID: 9792333 [Abstract] [Full Text] [Related]
9. The molecular complexity of glucocorticoid actions in inflammation - a four-ring circus. Goulding NJ. Curr Opin Pharmacol; 2004 Dec; 4(6):629-36. PubMed ID: 15525555 [Abstract] [Full Text] [Related]
10. Glucocorticoid-resistant asthma: more than meets the eye. Reddy D, Little FF. J Asthma; 2013 Dec; 50(10):1036-44. PubMed ID: 23923995 [Abstract] [Full Text] [Related]
11. Glucocorticoid insensitivity as a source of drug targets for respiratory disease. Ammit AJ. Curr Opin Pharmacol; 2013 Jun; 13(3):370-6. PubMed ID: 23434363 [Abstract] [Full Text] [Related]
12. Steroid resistance in asthma. Barnes PJ, Adcock IM. QJM; 1995 Jul; 88(7):455-68. PubMed ID: 7633872 [Abstract] [Full Text] [Related]
13. Update on glucocorticoid action and resistance. Ito K, Chung KF, Adcock IM. J Allergy Clin Immunol; 2006 Mar; 117(3):522-43. PubMed ID: 16522450 [Abstract] [Full Text] [Related]
14. [Effectiveness and safety of fluticasone propionate in therapy of children suffering from asthma. Part I. Mechanisms of actions and clinical effectiveness of treatment in children with asthma]. Bartkowiak-Emeryk M, Breborowicz A, Emeryk A, Kulus M, Kurzawa R, Lis G, Mazurek H, Niedziela M. Pol Merkur Lekarski; 2004 Mar; 17 Suppl 2():5-10. PubMed ID: 15688663 [Abstract] [Full Text] [Related]
15. Heterogeneity in mechanisms influencing glucocorticoid sensitivity: the need for a systems biology approach to treatment of glucocorticoid-resistant inflammation. Keenan CR, Radojicic D, Li M, Radwan A, Stewart AG. Pharmacol Ther; 2015 Jun; 150():81-93. PubMed ID: 25596317 [Abstract] [Full Text] [Related]
16. Mechanisms and resistance in glucocorticoid control of inflammation. Barnes PJ. J Steroid Biochem Mol Biol; 2010 May 31; 120(2-3):76-85. PubMed ID: 20188830 [Abstract] [Full Text] [Related]
17. Glucocorticosteroids: current and future directions. Barnes PJ. Br J Pharmacol; 2011 May 31; 163(1):29-43. PubMed ID: 21198556 [Abstract] [Full Text] [Related]
18. Mononuclear cells in corticosteroid-resistant asthma. Lane SJ, Lee TH. Am J Respir Crit Care Med; 1996 Aug 31; 154(2 Pt 2):S49-51; discussion S52. PubMed ID: 8756788 [No Abstract] [Full Text] [Related]
19. Therapeutic targets for new therapy for corticosteroid refractory asthma. Ito K, Mercado N. Expert Opin Ther Targets; 2009 Sep 31; 13(9):1053-67. PubMed ID: 19659447 [Abstract] [Full Text] [Related]
20. Corticosteroid therapy in asthma: predictors of responsiveness. Mjaanes CM, Whelan GJ, Szefler SJ. Clin Chest Med; 2006 Mar 31; 27(1):119-32, vii. PubMed ID: 16543057 [Abstract] [Full Text] [Related] Page: [Next] [New Search]